Adoptively transferred tumor-draining lymph node–derived T cells recognize the shared tumor antigen peptide on HLA class I via native TCRs and directly kill targets via perforin/granzyme release and Fas–FasL apoptosis, with supportive cytokine effects (e.g., IFN-γ, TNF).